About PMV Pharmaceuticals, Inc
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
Market Cap
$0.06B
Employees
47
Listed Since
September 25, 2020
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.pmvpharma.comPhone
(609) 642-6664
Headquarters
ONE RESEARCH WAY
PRINCETON, NJ 08540
CIK
0001699382